Strata Partners is delighted to announce that it acted as exclusive corporate finance adviser to Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”), a fully integrated contract research and manufacturing organization offering laboratory, CMC and clinical development services for the life science industry, on its acquisition of 100% of the equity of Absorption Systems for up to US$137.5 million in cash.